Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
312
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

806
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
806
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extrafacial involvement in lupus miliaris disseminatus faciei.

JAAD case reports·2026
Same author

Granuloma annulare: An updated review of epidemiology, molecular pathogenesis, and management.

Journal of the American Academy of Dermatology·2026
Same author

Artificial intelligence in dermatology: Clinical promise and environmental impact.

The Journal of investigative dermatology·2026
Same author

Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease.

JAMA dermatology·2026
Same author

Deuterated Pentoxifylline Analog in the Treatment of Necrobiosis Lipoidica: A Nonrandomized Clinical Trial.

JAMA dermatology·2026
Same author

A spatially coordinated keratinocyte-fibroblast circuit recruits MMP9<sup>+</sup> myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity.

Nature immunology·2026

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

393

Extrapulmonary sarcoidosis.

Paolo Spagnolo1, Vasileios Kouranos2, Victoria Singh-Curry3

  • 1Respiratory Disease Unit, Department of Cardiac Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Journal of Autoimmunity
|October 6, 2024
PubMed
Summary

Sarcoidosis is a chronic inflammatory disease affecting multiple organs, often the lungs. Early diagnosis and multidisciplinary care are crucial for managing this complex condition.

Keywords:
Cardiac sarcoidosisCutaneous sarcoidosisExtrapulmonary manifestationsNeurosarcoidosisOcular sarcoidosisSarcoidosisUveitis

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.7K

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

393
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.7K

Area of Science:

  • Immunology
  • Pulmonology
  • Rheumatology

Background:

  • Sarcoidosis is a multisystem granulomatous disease of unknown etiology.
  • Lung involvement is common, causing significant morbidity and mortality.
  • Extrapulmonary manifestations can affect the heart, nervous system, eyes, and skin, leading to severe outcomes.

Purpose of the Study:

  • To provide a comprehensive overview of sarcoidosis.
  • To highlight the diagnostic challenges, particularly with isolated extrapulmonary involvement.
  • To discuss current therapeutic strategies.

Main Methods:

  • Review of existing literature on sarcoidosis pathophysiology, clinical presentation, diagnosis, and treatment.
  • Emphasis on the importance of a multidisciplinary approach for complex cases.

Main Results:

  • Sarcoidosis diagnosis often relies on compatible clinical findings and biopsy confirmation.
  • Isolated extrapulmonary sarcoidosis presents diagnostic challenges.
  • Multisystem involvement necessitates expert specialist collaboration.

Conclusions:

  • Prompt diagnosis and multidisciplinary management are essential for sarcoidosis patients.
  • Corticosteroids are the primary treatment, with other agents used for refractory cases.
  • Understanding the diverse manifestations is key to effective patient care.